Cagrilintide + Semaglutide

Cagrilintide (5 mg) + Semaglutide (5 mg) is a dual-peptide research formulation supplied as a high-purity lyophilized powder blend, combining a long-acting amylin analog with a modified GLP-1 analog in a single vial format. This combination is manufactured under stringent conditions and characterized using validated analytical methods to confirm identity, structural integrity, purity, and batch-to-batch consistency for controlled laboratory applications.

For research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.

Storage: Lyophilized material should be stored refrigerated (2–8°C), protected from light. After reconstitution, store refrigerated (2–8°C) and use within a limited research window under appropriate laboratory handling conditions.

Every batch is tested by an independent third-party laboratory. Download the Certificate of Analysis for complete purity and composition data.